These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30220291)

  • 21. Predictive performance of a vancomycin-aminoglycoside population model.
    Beringer PM; Wong-Beringer A; Rho JP
    Ann Pharmacother; 1998 Feb; 32(2):176-81. PubMed ID: 9496400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased vancomycin clearance in patients with congestive heart failure.
    Shimamoto Y; Fukuda T; Tominari S; Fukumoto K; Ueno K; Dong M; Tanaka K; Shirasaka T; Komori K
    Eur J Clin Pharmacol; 2013 Mar; 69(3):449-57. PubMed ID: 22791272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive Performance of Vancomycin Trough Concentrations in Patients With Diabetes With Microalbuminuria.
    Kimura H; Shigematsu M; Tanaka A; Watanabe S; Takatori S; Tanaka M; Mizuma T; Araki H
    Ther Drug Monit; 2017 Dec; 39(6):614-616. PubMed ID: 28976419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Augmented renal clearance in critically ill patients: incidence, associated factors and effects on vancomycin treatment].
    Campassi ML; Gonzalez MC; Masevicius FD; Vazquez AR; Moseinco M; Navarro NC; Previgliano L; Rubatto NP; Benites MH; Estenssoro E; Dubin A
    Rev Bras Ter Intensiva; 2014; 26(1):13-20. PubMed ID: 24770684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic monitoring of intravenous vancomycin in a pediatric critical care unit].
    Villena R; González CA; Nalegach ME; Vásquez A; Villareal M; Drago M
    Rev Chilena Infectol; 2014 Jun; 31(3):249-53. PubMed ID: 25146197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
    Hermida J; Tutor JC
    Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vancomycin pharmacokinetics during high-volume continuous venovenous hemofiltration in critically ill septic patients.
    Petejova N; Martinek A; Zahalkova J; Duricova J; Brozmannova H; Urbanek K; Grundmann M; Plasek J; Kacirova I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):65-72. PubMed ID: 23132513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of distribution volume of vancomycin in critically ill patients using extravascular lung water and pulmonary vascular permeability indices.
    Imaura M; Yokoyama H; Kohyama T; Nagafuchi H; Kohata Y; Takahashi H; Yamada Y
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):814-20. PubMed ID: 22943925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.
    Radke C; Horn D; Lanckohr C; Ellger B; Meyer M; Eissing T; Hempel G
    Clin Pharmacokinet; 2017 Jul; 56(7):759-779. PubMed ID: 28039606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients: developing and testing of a dosing nomogram.
    Baptista JP; Roberts JA; Sousa E; Freitas R; Deveza N; Pimentel J
    Crit Care; 2014 Dec; 18(6):654. PubMed ID: 25475123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A population pharmacokinetic model of vancomycin for dose individualization based on serum cystatin C as a marker of renal function.
    Liu TT; Pang HM; Jing L; Wei WX; Qin XL; Guo Q; Lu H; Cheng DH; Jiang WZ
    J Pharm Pharmacol; 2019 Jun; 71(6):945-955. PubMed ID: 30873627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal dose of vancomycin for treating methicillin-resistant Staphylococcus aureus pneumonia in critically ill patients.
    Chung J; Oh JM; Cho EM; Jang HJ; Hong SB; Lim CM; Koh YS
    Anaesth Intensive Care; 2011 Nov; 39(6):1030-7. PubMed ID: 22165354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
    Roberts DM; Roberts JA; Roberts MS; Liu X; Nair P; Cole L; Lipman J; Bellomo R;
    Crit Care Med; 2012 May; 40(5):1523-8. PubMed ID: 22511133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and prospective validation of a dosing instrument for continuous infusion of vancomycin: a within-population approach.
    van Maarseveen EM; Bouma A; Touw DJ; Neef C; van Zanten AR
    Eur J Clin Pharmacol; 2014 Nov; 70(11):1353-9. PubMed ID: 25168621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
    Eiland LS; English TM; Eiland EH
    Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Race-Based and Non-Race-Based Equations for Kidney Function Estimation in Critically Ill Thai Patients for Vancomycin Dosing.
    Sitaruno S; Santimaleeworagun W; Pattharachayakul S; DeBacker KC; Vattanavanit V; Binyala W; Pai MP
    J Clin Pharmacol; 2022 Oct; 62(10):1215-1226. PubMed ID: 35543614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population pharmacokinetic parameters of vancomycin in critically ill patients.
    Llopis-Salvia P; Jiménez-Torres NV
    J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy.
    Economou CJP; Kielstein JT; Czock D; Xie J; Field J; Richards B; Tallott M; Visser A; Koenig C; Hafer C; Schmidt JJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2018 Aug; 52(2):151-157. PubMed ID: 29526606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients.
    Chuma M; Makishima M; Imai T; Tochikura N; Suzuki S; Kuwana T; Sawada N; Komatsu T; Sakaue T; Kikuchi N; Yoshida Y; Kinoshita K
    Ther Drug Monit; 2018 Feb; 40(1):109-114. PubMed ID: 29095798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute kidney injury during vancomycin therapy in critically ill children.
    Totapally BR; Machado J; Lee H; Paredes A; Raszynski A
    Pharmacotherapy; 2013 Jun; 33(6):598-602. PubMed ID: 23526674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.